Please assess the completion status of the following clinical trial:

Trial Title: EDWARDS INTUITY Valve System CADENCE-MIS Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion:~1. adult male or female ≥18 years of age~2. symptomatic for aortic stenosis / mixed aortic stenosis and aortic insufficiency disease for which isolated surgical aortic valve replacement without concomitant procedures is planned~3. EuroSCORE \<20~4. NYHA Class ≥II~5. Subject has signed and dated the investigation informed consent form prior to study specific procedures are performed~6. Subject is geographically stable and agrees to participate in follow-up assessments as specified in the protocol and informed consent~Exclusion (i.a.):~1. pure aortic insufficiency~2. previous cardiac surgery (involved FS or MIS approach)~3. congenital true bicuspid / unicuspid aortic valve~4. requires emergency surgery or has had emergency surgery for any reason~   ≤ 1 month before the intended treatment~5. LVEF \<25%~6. active endocarditis ≤ 6 months before the intended treatment~7. acute MI ≤ 90 days before the intended treatment~8. had a stroke or transient ischemic attack within six months prior to scheduled aortic valve replacement surgery~9. oxygen or ventilator dependent~10. life expectancy \< 12 months~11. substance abuser~12. Female subject is pregnant or lactating~13. documented leukopenia (WBC \< 3.5x 103/μL), acute anemia (Hgb \< 10.0 gm/dL or \< 6.2 mmol/L), thrombocytopenia (platelet count \< 100x 103/mL), or history of bleeding diathesis or coagulopathy~14. hemodynamic or respiratory instability requiring inotropic support, mechanical circulatory support, or mechanical ventilation within 30 days of procedure~15. documented echocardiographic evidence of intracardiac mass, thrombus or vegetation~16. renal insufficiency as determined by Serum creatinine ≥ 200 μmol/L (2.27 mg/dL) at screening or end-stage renal disease requiring chronic dialysis~17. documented hyperparathyroidism~18. currently participating in an investigational drug or device trial for which follow-up has not yet been completed~19. Minimally Invasive access to the heart is not possible due to anatomical constraints or any other pre-existing condition~Intra-operative Exclusion:~1. has calcium on the anterior mitral leaflet which cannot be removed~2. has extensive calcification of the aortic root~3. Annular deformation which may or may not be caused by too extensive decalcification of the aortic annulus~4. has left atrial thrombus~5. The position of the coronary ostia relative to the EDWARDS INTUITY Valve would result in obstruction of blood flow~6. hemodynamically unstable during the procedure requiring the procedure to be aborted prior to insertion of the study bioprosthesis and delivery system~7. Study device is not available in the correct size for the subject

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- EDWARDS INTUITY (Type: ACTIVE_COMPARATOR): EDWARDS INTUITY Valve System, Model 8300A
- Stented Aortic Bioprostheses (Type: ACTIVE_COMPARATOR): Stented Aortic Bioprostheses

Based on this trial design, predict the completion outcome and termination type (if applicable).